Actions | Comments |
ABC | Urgent management of airway, ventilation, and circulation is vital in patients who have decreased levels of consciousness. Supplemental oxygen is not recommended in nonhypoxic patients. If GCS < 9 assess for ITU bed. Intubation for those who cannot protect airway and ventilate those not breathing. End of life care may be more appropriate in catastrophic stroke. Assess NIHSS |
Blood glucose | Treat and manage any hypoglycaemia by fingerstick blood draw is acceptable |
Assess those with Ischaemic stroke for Stroke Thrombolysis | Consider for Stroke Thrombolysis and administer recombinant tissue plasminogen activator within 3 hours (age >80) or 4.5 hrs if Age (<=80) of symptom onset, after appropriate screening for ischaemic stroke. Non contrast CT scan. Determine eligibility for thrombolytic therapy. Ensure door to needle time < 30 mins. Avoid in Patients with known or suspected bleeding diathesis or anticoagulant use: review coagulation studies and platelet count to ascertain eligibility before proceeding |
Assess those with Ischaemic stroke for Thrombectomy | If anticipating Mechanical Thrombectomy then get an urgent CTA to look for large vessel obstruction as early as possible but within 6 hours; may be considered in select patients for window of up to 16 to 24 hours with the aim being reperfusion to a modified thrombolysis in cerebral infarction 2b/3 angiographic result to maximize the probability of a good functional clinical outcome |
Haemorrhagic stroke or Ischaemic stroke and raised ICP | Discuss need for neurosurgical intervention as appropriate. May need Shunting for those with hydrocephalus or Sub-occipital craniectomy for cerebellar bleeds or Neurosurgical referral for Clot evacuation or Decompressive Hemicraniectomy for malignant MCA syndrome or Coiling or clipping for those with SAH |
Haemorrhagic stroke and coagulopathy | 4 factor Prothrombin complex concentrates and Vitamin K for Warfarin or DOAC induced bleeds. Praxbind for Dabigatran. Platelets for thrombocytopenia |
Actions | Comments |
Age of patient | Defines thrombolysis window. Aged < 80 we treat up to 4.5 hrs and over 80 only 3 hrs |
Time since last well | Time of onset is very useful but if this is unclear we must use Time since last well and time found and work out when we think time of onset was to some degree of accuracy if possible to help define the window |
Anticoagulation | Being anticoagulated contraindicates thrombolysis but not thrombectomy |
NIHSS | Tells us severity of stroke. We don't usually offer reperfusion therapies on those with small (NIHSS<4) or very large (>25) strokes |
Premorbid state | Thrombolysis/thrombectomy reduce dependency. If already dependent then benefits less. |
CT report | We will look at it but do not refer for reperfusion (thrombolysis/thrombectomy) if haemorrhage or tumour or advanced stroke changes suggesting stroke is older than thought. If unsure discuss. |
Comorbidities | If the patient has advanced malignancy or other diseases possibly contraindicating alteplase. Any recent bleeding issues or trauma must be noted and any non-investigated severe anaemia. |
Blood pressure | Need BP < 185/110 mmHg to give alteplase. |
Managing and Preventing Early complications |
Bedside Swallow assessment | Checking safe swallow before oral intake reduces aspiration |
Feeding | NG tube placement for feeding when appropriate |
VTE prevention | Using methods to prevent VTE - Intermittent pneumatic calf compression, LMWH, Early mobilisation |
Hydrate | IV fluids to prevent dehydration in those unable to drink |
Skin care | Regular turns and monitoring to prevent skin damage and ulcers |
Bowels | Bowel management to prevent constipation |
Shoulder | Prevention of shoulder damage and postural problems |
Therapy | Early rehabilitation to enable recovery |
Seizures | Management of seizures |
Infections | Management of infections - UTI, RTI |
Bladder | Management of continence, avoidance of catheterisation where possible |